Oral Versus Intravenous Antibiotic Prophylaxis Before Obstetric and Gynecological Procedures

NCT06255652 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2024-02-13

No results posted yet for this study

Summary

Oral versus intravenous antimicrobial prophylaxis for the prevention of surgical site infection for elective cesarean section and gynacological procedures

Conditions

  • Site Infection

Interventions

DRUG

Cephradin

Velosef

Sponsors & Collaborators

  • Randers Regional Hospital

    collaborator OTHER
  • Sohag University

    lead OTHER

Principal Investigators

  • Hatem Awaga Awaga, Doctor · Sohag University

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-01
Primary Completion
2024-07-31
Completion
2024-07-31
FDA Drug
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06255652 on ClinicalTrials.gov